MiraeING.Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 16, 2022 at 02:07 am EDT
Share
MiraeING.Co.,Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was KRW 2,565.95 million compared to KRW 2,309.12 million a year ago. Net loss was KRW 5,081.25 million compared to net income of KRW 568.82 million a year ago. Basic loss per share from continuing operations was KRW 195 compared to basic earnings per share from continuing operations of KRW 20 a year ago. Diluted loss per share from continuing operations was KRW 195 compared to diluted earnings per share from continuing operations of KRW 20 a year ago. Basic loss per share was KRW 195 compared to basic earnings per share of KRW 20 a year ago.
For the six months, sales was KRW 4,543.35 million compared to KRW 4,247.29 million a year ago. Net loss was KRW 5,735.5 million compared to net income of KRW 2,219.22 million a year ago. Basic loss per share from continuing operations was KRW 225 compared to basic earnings per share from continuing operations of KRW 45 a year ago. Diluted loss per share from continuing operations was KRW 225 compared to diluted earnings per share from continuing operations of KRW 45 a year ago. Basic loss per share was KRW 225 compared to basic earnings per share of KRW 90 a year ago.
MiraeING.Co.,Ltd., formerly Theall Medi Bio. Co.,Ltd., is a Korea-based company mainly engaged in solution business and video business. The Company operates in three main segments: solution segment, which provides project consulting, construction and maintenance services and related products for banks under the brand name XiT, eNisis and others; video segment, which provides digital video recorders (DVRs) and closed circuit television (CCTV) systems for security areas, and defense segment, which provides self-propelled artilleries and components. It also engages in the leasing of non-residential buildings.